スピルリナの世界市場:種類別(アルスロスピラプラテンシス、アルスロスピラマキシマ)、用途別(栄養補助食品、化粧品、食品および飲料、動物飼料、その他)、製剤別(粉末、錠剤・カプセル、液体、顆粒、ゲル化剤)...市場調査レポートについてご紹介

【英文タイトル】Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Cosmetics, Food & Beverages, Animal Feed, and Others), and Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings

2.1.1. Top impacting factors
2.1.2. Top investment pockets

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Spirulina Market

3.3.1. Low-to-high bargaining power of suppliers
3.3.2. Moderate-to-high threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Low-to-moderate bargaining power of buyers

3.4. Pricing Analysis

3.4.1. Pricing Analysis, By Region, 2018 & 2025

3.5. Value Chain Analysis
3.6. Impact of government regulations on global spirulina market
3.7. Industry Pain point analysis
3.8. Patent Analysis

3.8.1. By Region (2016-2018)
3.8.2. By Applicant

3.9. Case Studies

3.9.1. Case Study 01

3.10. Market dynamics

3.10.1. Drivers

3.10.1.1. Rise in demand for natural ingredient
3.10.1.2. Promotion of the production of spirulina by government
3.10.1.3. R&D of spirulina as commercial products

3.10.2. Restraints

3.10.2.1. Impact on spirulina production due to climate change

3.10.3. Opportunities

3.10.3.1. Untapped markets in the developing countries
3.10.3.2. Easy to cultivate due to development in cultivation technology

CHAPTER 4: SPIRULINA MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Arthrospira Platensis

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Arthrospira Maxima

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: SPIRULINA MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Nutraceuticals

5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country

5.3. Cosmetics

5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country

5.4. Food and Beverages

5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country

5.5. Animal Feed

5.5.1. Key market trends and opportunities
5.5.2. Market size and forecast
5.5.3. Market analysis, by country

5.6. Other applications

5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast
5.6.3. Market analysis, by country

CHAPTER 6: SPIRULINA MARKET, BY DRUG FORMULATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Powder

6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country

6.3. Tablet & Capsule

6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country

6.4. Liquid

6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast
6.4.3. Market analysis, by country

6.5. Granule & Gelling Agent

6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast
6.5.3. Market analysis, by country

CHAPTER 7: SPIRULINA MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by type
7.2.3. North America market size and forecast, by application
7.2.4. North America market size and forecast, by drug formulation
7.2.5. North America market size and forecast, by country

7.2.5.1. U.S. market size and forecast, by type
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by drug formulation
7.2.5.4. Canada market size and forecast, by type
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by drug formulation
7.2.5.7. Mexico market size and forecast, by type
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by drug formulation

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by type
7.3.3. Europe market size and forecast, by application
7.3.4. Europe market size and forecast, by drug formulation
7.3.5. Europe market size and forecast, by country

7.3.5.1. France market size and forecast, by type
7.3.5.2. France market size and forecast, by application
7.3.5.3. France market size and forecast, by drug formulation
7.3.5.4. UK market size and forecast, by type
7.3.5.5. UK market size and forecast, by application
7.3.5.6. UK market size and forecast, by drug formulation
7.3.5.7. Italy market size and forecast, by type
7.3.5.8. Italy market size and forecast, by application
7.3.5.9. Italy market size and forecast, by drug formulation
7.3.5.10. Spain market size and forecast, by type
7.3.5.11. Spain market size and forecast, by application
7.3.5.12. Spain market size and forecast, by drug formulation
7.3.5.13. Rest of Europe market size and forecast, by type
7.3.5.14. Rest of Europe market size and forecast, by application
7.3.5.15. Rest of Europe market size and forecast, by drug formulation

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by type
7.4.3. Asia-Pacific market size and forecast, by application
7.4.4. Asia-Pacific market size and forecast, by drug formulation
7.4.5. Asia-Pacific market size and forecast, by country

7.4.5.1. Japan market size and forecast, by type
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by drug formulation
7.4.5.4. China market size and forecast, by type
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by drug formulation
7.4.5.7. India market size and forecast, by type
7.4.5.8. India market size and forecast, by application
7.4.5.9. India market size and forecast, by drug formulation
7.4.5.10. Australia market size and forecast, by type
7.4.5.11. Australia market size and forecast, by application
7.4.5.12. Australia market size and forecast, by drug formulation
7.4.5.13. South Korea market size and forecast, by type
7.4.5.14. South Korea market size and forecast, by application
7.4.5.15. South Korea market size and forecast, by drug formulation
7.4.5.16. Rest of Asia-Pacific market size and forecast, by type
7.4.5.17. Rest of Asia-Pacific market size and forecast, by application
7.4.5.18. Rest of Asia-Pacific market size and forecast, by drug formulation

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by type
7.5.3. LAMEA market size and forecast, by application
7.5.4. LAMEA market size and forecast, by drug formulation
7.5.5. LAMEA market size and forecast, by country

7.5.5.1. Brazil market size and forecast, by type
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by drug formulation
7.5.5.4. South Africa market size and forecast, by type
7.5.5.5. South Africa market size and forecast, by application
7.5.5.6. South Africa market size and forecast, by drug formulation
7.5.5.7. Rest of LAMEA market size and forecast, by type
7.5.5.8. Rest of LAMEA market size and forecast, by application
7.5.5.9. Rest of LAMEA market size and forecast, by drug formulation

CHAPTER 8: COMPANY PROFILES

8.1. Algenol Biofuels Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio

8.2. Dongtai City Spirulina Bio-engineering Co, Ltd.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio

8.3. CHR. HANSEN HOLDING A/S

8.3.1. Company overview
8.3.2. CHR. Hansen: company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. CYANOTECH CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DDW Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. DIC CORPORATION

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. DÖHLER GMBH

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. FMC CORPORATION

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. Givaudan International SA

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. KONINKLIJKE DSM N.V.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

8.11. Prolgae

8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance

8.12. SENSIENT TECHNOLOGIES CORPORATION

8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance

8.13. E.I.D. Parry Limited

8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance


【レポート販売概要】

■ タイトル:スピルリナの世界市場:種類別(アルスロスピラプラテンシス、アルスロスピラマキシマ)、用途別(栄養補助食品、化粧品、食品および飲料、動物飼料、その他)、製剤別(粉末、錠剤・カプセル、液体、顆粒、ゲル化剤)
■ 英文:Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Cosmetics, Food & Beverages, Animal Feed, and Others), and Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年5月6日
■ 調査会社:Allied Market Research
■ 商品コード:AMR9AG003
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。